G&K Services, Inc. is a service-focused provider of branded uniform and facility services programs. The Company provides a range of workwear and protective safety apparel through rental and direct purchase programs. The Company also supplies various facility products and services, including floor mats, towels, mops, restroom hygiene products, and first aid supplies. It also manufactures certain work apparel garments that are used to support its garment rental and direct purchase programs. It operates in two segments: United States (includes the Dominican Republic) and Canada. The Company operated from approximately 160 locations, as of July 2, 2016. The Company serves a diverse base of customer locations in various industries, including automotive, warehousing, distribution, transportation, energy, manufacturing, food processing, retail, restaurants, construction and trades, hospitality, government, healthcare and others.
News about GK
These Numbers May Change Your Mind About MoviePass
Thesis Helios and Matheson Analytics (HMNY), better known as the majority owner of MoviePass, reported first quarter results which showed a profit. Is this real? Does this mean that they are finally on their way to profitability? I show why you shoul...Read More>>>
Crude Oil's Surge Is Putting the ‘Petro’ Back in Petrocurrencies
The currencies of some of the world’s top oil producers are set to become intertwined with crude prices once again as the commodity surges to the highest since 2014.After shedding much of their linkage to oil last year, Norway’s krone a...Read More>>>
3 Top Biotech Stocks to Buy Right Now
Human understanding of biology is progressing like never before. Those advancements could ultimately help millions of humans live longer, better lives. For investors, the companies that are helping to move the ball forward could create vast wealth fo...Read More>>>
DekaBank Deutsche Girozentrale Buys 25,800 Shares of Epizyme (EPZM)
DekaBank Deutsche Girozentrale raised its stake in shares of Epizyme (NASDAQ:EPZM) by 77.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 59,100 shares of t...Read More>>>
Syndax Pharmaceuticals: What Investors Can Expect From This Potential Grower?
Do what you like and are good at. - Charlie Munger Syndax Pharmaceuticals (NASDAQ:SNDX) is an intriguing bioscience alerted to us by members of Integrated BioSci Investing. The company is innovating a stellar therapeutic pipeline that can deliver ...Read More>>>